The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 26, 2020

Filed:

Jun. 05, 2018
Applicant:

Shire Human Genetic Therapies, Inc., Lexington, MA (US);

Inventors:

Nazila Salamat-Miller, Arlington, MA (US);

Katherine Taylor, Arlington, MA (US);

Paul Campolieto, Charlottesville, VA (US);

Zahra Shahrokh, Weston, MA (US);

Jing Pan, Boxborough, MA (US);

Lawrence Charnas, Natick, MA (US);

Teresa Leah Wright, Lexington, MA (US);

Pericles Calias, Melrose, MA (US);

Keethkumar Jain, Brighton, MA (US);

Sujit Basu, Newton, MA (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/46 (2006.01); A61K 9/00 (2006.01); A61K 9/19 (2006.01); A61K 38/51 (2006.01); A61K 47/10 (2017.01);
U.S. Cl.
CPC ...
A61K 38/465 (2013.01); A61K 9/0019 (2013.01); A61K 9/0085 (2013.01); A61K 9/19 (2013.01); A61K 38/51 (2013.01); A61K 47/10 (2013.01); C12Y 301/06008 (2013.01);
Abstract

The present invention provides, among oilier things, compositions and methods for CNS delivery of lysosomal enzymes (e.g., recombinant human arylsulfatase A (rhASA)) for effective treatment of lysosomal storage diseases (e.g. Metachromatic Leukodystrophy Disease), In some embodiments, the present invention includes a stable formulation for intrathecal administration comprising an ASA protein and a poloxamer, wherein less than 3% of the ASA protein exists in aggregated form.


Find Patent Forward Citations

Loading…